Acinetobacter baumannii reinforces the pathogenesis by promoting IL-17 production in a mouse pneumonia model

Yangyang Zhou1, Chuanying Xiang1, Ning Wang1

  • 1West China Biopharmaceutical Research Institute, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China.

Insights

Interleukin-17 (IL-17) exacerbates Acinetobacter baumannii pneumonia by suppressing neutrophil function. Targeting IL-17 may improve outcomes for this serious bacterial lung infection.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Pulmonology

Background:

  • Interleukin-17 (IL-17) plays a role in host defense against bacterial infections.
  • The specific role of IL-17 in Acinetobacter baumannii pneumonia is not well understood.

Purpose of the Study:

  • To investigate the role of IL-17 in a mouse model of pulmonary Acinetobacter baumannii infection.
  • To determine the impact of IL-17 on host defense mechanisms, particularly neutrophil function.

Main Methods:

  • Intra-tracheal instillation of Acinetobacter baumannii in C57BL/6 mice to induce pneumonia.
  • Comparison of wild-type and IL-17-deficient (Il17-/-) mice.
  • Analysis of survival, bacterial burden, lung inflammation, and neutrophil infiltration and phagocytosis via flow cytometry.

Main Results:

  • Acinetobacter baumannii infection increased IL-17 expression in the lungs.
  • IL-17-deficient mice exhibited increased survival, reduced bacterial load, and less lung inflammation compared to wild-type mice.
  • IL-17 treatment exacerbated pneumonia severity and suppressed neutrophil phagocytic function in infected mice.

Conclusions:

  • IL-17 plays a pathogenic role in Acinetobacter baumannii pneumonia by impairing neutrophil phagocytosis.
  • Targeting IL-17 presents a potential therapeutic strategy for managing Acinetobacter baumannii pneumonia.

Related Concept Videos